MedTrace Logo

Pethidine Analgesia and Neonatal Hearing Screening Test

NCT04014504 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2019-07-12

No results posted yet for this study

Summary

Neonatal hearing screening may fail due to some perinatal and neonatal factors. It is well known that false positivity in newborn hearing screening increases cost and maternal anxiety and anxiety. There is still widespread concern about the use of opoid analgesics to relieve pain during labor. The aim of this study was to determine the effects of pethidine administered during labor on neonatal hearing screening test false positivity rates.

Conditions

Interventions

DIAGNOSTIC_TEST

Neonatal Hearing Screening Test

neonatal hearing screening test results will be evaluated.

Sponsors & Collaborators

  • Kanuni Sultan Suleyman Training and Research Hospital

    lead OTHER

Eligibility

Min Age
24 Hours
Max Age
14 Days
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2018-01-01
Completion
2018-01-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04014504 on ClinicalTrials.gov